Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

11. Juni 2018 09:00 ET | Quelle: Therapeutic Solutions International, Inc.

Therapeutic Solutions International Expands Adoptive Immunotherapy Portfolio by Incorporation of "Universal Cancer Antigen" into StemVacs Dendritic Cell Platform

OCEANSIDE, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire --Therapeutics Solutions International, Inc., (OTC Markets:TSOI) announced today initiation of efforts to combine its existing...
31. Mai 2018 09:00 ET | Quelle: Therapeutic Solutions International, Inc.

Therapeutic Solutions International to Provide Patients Access to StemVacs Cancer Immunotherapy through Newly Passed Right to Try Law

OCEANSIDE, Calif., May 31, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Therapeutics Solutions International, Inc., (OTC Markets:TSOI) announced today their plans to provide access to its clinical...
01. Mai 2018 09:00 ET | Quelle: Therapeutic Solutions International, Inc.

Therapeutic Solutions International Launches Multi-Protocol Cancer Immunotherapy Clinical Trial with Pan Am Cancer Treatment Centers

Company Aims to Leverage Transfer Factor Pulsed Autologous Dendritic Cells on StemVacs Platform withPatented Augmenter of Cancer Immunotherapy NanoStilbene OCEANSIDE, Calif., May 01, 2018 ...